These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Hemodynamic effects of various doses of a new inotropic: amrinoma]. Cárdenas M; Vidaurri A Arch Inst Cardiol Mex; 1979; 49(5):961-8. PubMed ID: 122781 [TBL] [Abstract][Full Text] [Related]
5. [Effects of amrinone, a new non-digitalic positive inotropic agent, on the efficiency and coronary circulation of the heart]. Bárcenas L; Kabela E Arch Inst Cardiol Mex; 1984; 54(5):431-40. PubMed ID: 6517640 [TBL] [Abstract][Full Text] [Related]
6. Amrinone: a promising new cardiotonic agent in the treatment of chronic cardiac failure. Likoff MJ; Weber KT; Andrews V; Janicki JS Herz; 1983 Aug; 8(4):199-205. PubMed ID: 6413341 [No Abstract] [Full Text] [Related]
7. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2. Colucci WS; Wright RF; Braunwald E N Engl J Med; 1986 Feb; 314(6):349-58. PubMed ID: 2418353 [No Abstract] [Full Text] [Related]
9. Hemodynamic effects of intravenous and oral amrinone in patients with severe heart failure: relationship between intravenous and oral administration. LeJemtel TH; Keung EC; Schwartz WJ; Maskin CS; Greenberg MA; Davis RS; Forman R; Ribner HS; Sonnenblick EH Trans Assoc Am Physicians; 1979; 92():325-33. PubMed ID: 549256 [No Abstract] [Full Text] [Related]
10. Haemodynamic effects of intravenous amrinone in patients with impaired left ventricular function. Wilmshurst PT; Thompson DS; Jenkins BS; Coltart DJ; Webb-Peploe MM Br Heart J; 1983 Jan; 49(1):77-82. PubMed ID: 6821613 [TBL] [Abstract][Full Text] [Related]
11. Amrinone: acute electrophysiologic and hemodynamic effects in patients with congestive heart failure. Naccarelli GV; Gray EL; Dougherty AH; Hanna JE; Goldstein RA Am J Cardiol; 1984 Sep; 54(6):600-4. PubMed ID: 6475780 [TBL] [Abstract][Full Text] [Related]
12. [Amrinone, a new cardiotonic agent]. Taira N Nihon Rinsho; 1983 Dec; 41(12):2691-7. PubMed ID: 6371299 [No Abstract] [Full Text] [Related]
13. Amrinone--a new inotropic agent in chronic resistant congestive cardiac failure. Robinson PJ; Lvoff R; Chong B; Barrett PA Aust N Z J Med; 1981 Dec; 11(6):666-8. PubMed ID: 6949545 [TBL] [Abstract][Full Text] [Related]
14. Effects of prenalterol in congestive heart failure. Hjalmarson A; Abelardo N; Waagstein E Eur Heart J; 1982 Dec; 3 Suppl D():115-21. PubMed ID: 7160397 [No Abstract] [Full Text] [Related]
15. Intravenous amrinone for congestive heart failure. Med Lett Drugs Ther; 1984 Nov; 26(675):104-5. PubMed ID: 6390109 [No Abstract] [Full Text] [Related]
16. [Oral and injectable amrinone in cardiac insufficiency]. Massabuau P; Puel J; Miquel JP; Bounhoure JP Ann Cardiol Angeiol (Paris); 1984; 33(4):223-6. PubMed ID: 6465816 [TBL] [Abstract][Full Text] [Related]
17. [Effects of amrinone on hemodynamics, oxygen consumption and plasma catecholamine levels in anesthetized dogs]. Kosugi I; Gonda T; Okada K; Tajimi K; Moriyasu N; Fukatsu O Masui; 1985 Apr; 34(4):429-33. PubMed ID: 4021088 [No Abstract] [Full Text] [Related]
18. Failure of low doses of amrinone to produce sustained hemodynamic improvement in patients with severe chronic congestive heart failure. Packer M; Medina N; Yushak M Am J Cardiol; 1984 Nov; 54(8):1025-9. PubMed ID: 6496324 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of intravenous amrinone: the first of a new class of positive inotropic agents with vasodilator properties. Bottorff MB; Rutledge DR; Pieper JA Pharmacotherapy; 1985; 5(5):227-37. PubMed ID: 3906583 [TBL] [Abstract][Full Text] [Related]
20. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug. Hermiller JB; Leithe ME; Magorien RD; Unverferth DV; Leier CV J Pharmacol Exp Ther; 1984 Feb; 228(2):319-26. PubMed ID: 6694112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]